Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Gracell Biotechnologies Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Unchanged |
2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL |
Vivo Opportunity Fund Holdings, L.P. | 38,152,030 7.700% |
0 (Unchanged) |
Filing |
| 2023-08-18 4:56 pm Purchase |
2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL |
Vivo Opportunity Fund Holdings, L.P. | 38,152,030 7.800% |
38,152,030 (New Position) |
Filing |